Here we show that patients (LGG + GBM) with a high PRKRA/CHROMR ratio (above the third quartile) had a higher survival rate than those below the third quartile (Hazard Ratio = 0.2), though our data did not reach statistical significance (Log-rank test, p = 0.0834) (Figure 3A). This evidence concerns the gene PRKRA and glioblastoma.